Bochman,
There were several reasons including competition, product effectiveness & price discounting.
Axiron, as I understand, is used only by those with a testosterone deficiency & consequently may not be of use to those who use alternative products which may mean that their market, although sizable, is limited in comparison to the overall market.
I am not an expert regarding all the other products & which dysfunction they address.
It was mainly the need to discount that would reduce the future expectations regarding revenue.
- Forums
- ASX - By Stock
- ACR
- stock being shorted
stock being shorted, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $16.57M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.5¢ | $18.68K | 321.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8498 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 225946 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8498 | 0.057 |
2 | 18938 | 0.056 |
2 | 36181 | 0.055 |
1 | 18800 | 0.053 |
1 | 88000 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 225946 | 1 |
0.060 | 423988 | 3 |
0.061 | 100000 | 1 |
0.062 | 116100 | 2 |
0.063 | 100000 | 1 |
Last trade - 15.59pm 06/09/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |